Publicacións en colaboración con investigadores/as de TRIUMF (19)

2011

  1. Age-specific progression of nigrostriatal dysfunction in Parkinson's disease

    Annals of Neurology, Vol. 69, Núm. 5, pp. 803-810

  2. Longitudinal evolution of compensatory changes in striatal dopamine processing in Parkinson's disease

    Brain, Vol. 134, Núm. 11, pp. 3290-3298

2010

  1. Dopamine transporter PET in normal aging: Dopamine transporter decline and its possible role in preservation of motor function

    Synapse, Vol. 64, Núm. 2, pp. 146-151

  2. Dopamine turnover increases in asymptomatic LRRK2 mutations carriers

    Movement Disorders, Vol. 25, Núm. 16, pp. 2717-2723

  3. Effects of expectation on placebo-induced dopamine release in Parkinson disease

    Archives of General Psychiatry, Vol. 67, Núm. 8, pp. 857-865

2009

  1. Dopamine transporter relation to levodopa-derived synaptic dopamine in a rat model of Parkinson's: An in vivo imaging study

    Journal of Neurochemistry, Vol. 109, Núm. 1, pp. 85-92

  2. Longitudinal progression of sporadic Parkinson's disease: A multi-tracer positron emission tomography study

    Brain, Vol. 132, Núm. 11, pp. 2970-2979

  3. PET demonstrates reduced dopamine transporter expression in PD with dyskinesias

    Neurology, Vol. 72, Núm. 14, pp. 1211-1216

  4. Visualizing vesicular dopamine dynamics in Parkinson's disease

    Synapse, Vol. 63, Núm. 8, pp. 713-716

2007

  1. Dopamine transporter relation to dopamine turnover in Parkinson's disease: A positron emission tomography study

    Annals of Neurology, Vol. 62, Núm. 5, pp. 468-474

2004

  1. Changes of dopamine turnover in the progression of Parkinson's disease as measured by positron emission tomography: Their relation to disease-compensatory mechanisms

    Journal of Cerebral Blood Flow and Metabolism, Vol. 24, Núm. 8, pp. 869-876

  2. Impact of the spatial normalization template and realignment procedure on the SPM analysis of [11C]raclopride PET studies

    IEEE Transactions on Nuclear Science, Vol. 51, Núm. 1 I, pp. 205-211

  3. Lack of regional selectivity during the progression of Parkinson disease: Implications for pathogenesis

    Archives of Neurology, Vol. 61, Núm. 12, pp. 1920-1925

2003

  1. Age and severity of nigrostriatal damage at onset of Parkinson's disease

    Synapse, Vol. 47, Núm. 2, pp. 152-158

  2. Effect of dopamine loss and the metabolite 3-O-methyl-[18F]fluoro-dopa on the relation between the 18F-fluorodopa tissue input uptake rate constant Kocc and the [18F]fluorodopa plasma input uptake rate constant Ki

    Journal of Cerebral Blood Flow and Metabolism, Vol. 23, Núm. 3, pp. 301-309

  3. VMAT2 binding is elevated in dopa-responsive dystonia: Visualizing empty vesicles by PET

    Synapse, Vol. 49, Núm. 1, pp. 20-28

2002

  1. Dopamine release in human ventral striatum and expectation of reward

    Behavioural Brain Research, Vol. 136, Núm. 2, pp. 359-363

  2. Impact of Different Realignment Algorithms on the SPM Analysis of [ 11C]Raclopride PET Studies

    IEEE Nuclear Science Symposium and Medical Imaging Conference

2000

  1. In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease

    Annals of Neurology, Vol. 47, Núm. 4, pp. 493-503